Tasly Pharmaceutical Group Co., Ltd

This early-stage study is testing the safety and early signs of effectiveness of a single intravenous infusion of donor-derived stem cells (called B2065) for people who have just had an ischemic stroke. The main goal is to see if the treatment is safe and well-tolerated when give…

This study is testing an experimental cell therapy called P134 for adults whose aggressive brain cancer (glioblastoma) has come back. Doctors will give patients modified immune cells (CAR-T cells) designed to target the tumor and see if it is safe and can help control the cancer.…

This trial is testing whether injecting stem cells from umbilical cords directly into the heart muscle during bypass surgery can help repair damage and improve heart function in people with chronic heart failure. The study will involve 51 participants who are already scheduled fo…

This study is testing whether Lianxiaxiaopi Granules, a traditional Chinese herbal medicine, can safely reduce symptoms of postprandial distress syndrome—a condition causing bothersome fullness and early satiety after eating. It is a large, Phase 3 trial where 342 adults will be …